Partnership would bypass drug industry to sell COVID-19 vaccine

Partnership would bypass drug industry to sell COVID-19 vaccine

A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed by a laboratory at Imperial College London.

The move would mean the could be sold without profits or licensing fees in Britain and in low- and , The New York Times reported. To be successful, a vaccine against the new coronavirus would have to be available at the lowest possible price and according to need rather than profit.

The Imperial College London lab has technology that may enable it to create a vaccine that is cheaper and easier to produce than others, said project lead scientist Robin Shattock, The Times reported.

Clinical trials of the vaccine are scheduled to start this month. If it proves safe and effective, the vaccine could become available early next year.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: The New York Times Article

Copyright © 2020 HealthDay. All rights reserved.

Citation: Partnership would bypass drug industry to sell COVID-19 vaccine (2020, June 9) retrieved 12 May 2021 from https://medicalxpress.com/news/2020-06-partnership-bypass-drug-industry-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments